The technology offers a distinct, patch-based approach to delivering beta radiation directly to skin cancers and superficial lesions. It enables precise surface treatment while minimizing exposure to underlying healthy tissue.

Colorado-based OncoPatch designed its system to deliver targeted radiation therapy to superficial lesions in dermatology settings with appropriate, authorized user oversight. It may be used as a primary treatment or for residual disease following excision of primary or recurrent skin tumors.

OncoPatch says its device can deliver therapy in a short course of just 1-5 sessions. The company aims to expand treatment options while supporting patient convenience and cosmetic outcomes.